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Abstract
Background: Alterations to cellular and molecular programs with brain aging result in cognitive impairment and
susceptibility to neurodegenerative disease. Changes in DNA methylation patterns, an epigenetic modification
required for various CNS functions are observed with brain aging and can be prevented by anti-aging interventions,
but the relationship of altered methylation to gene expression is poorly understood.
Results: Paired analysis of the hippocampal methylome and transcriptome with aging of male and female mice
demonstrates that age-related differences in methylation and gene expression are anti-correlated within gene bod‑
ies and enhancers. Altered promoter methylation with aging was found to be generally un-related to altered gene
expression. A more striking relationship was found between methylation levels at young age and differential gene
expression with aging. Highly methylated gene bodies and promoters in early life were associated with age-related
increases in gene expression even in the absence of significant methylation changes with aging. As well, low levels
of methylation in early life were correlated to decreased expression with aging. This relationship was also observed in
genes altered in two mouse Alzheimer’s models.
Conclusion: DNA methylation patterns established in youth, in combination with other epigenetic marks, were able
to accurately predict changes in transcript trajectories with aging. These findings are consistent with the develop‑
mental origins of disease hypothesis and indicate that epigenetic variability in early life may explain differences in
aging trajectories and age-related disease.
Keywords: DNA methylation, Aging, Epigenetics, Gene regulation, Hippocampus
Introduction
Epigenetic modifications, chromatin, and direct DNA
modifications are key genomic regulatory processes
required for proper development [1], gene imprinting
[2–4], X chromosome inactivation [5–7], gene expression
regulation [8], and genomic organization [9–11]. Disruptions to the epigenome can alter basic cellular regulation leading to a wide range of dysfunctional molecular
programs [10–12]. Dysregulated epigenetic control with
aging has been proposed as an etiological factor common to age-related diseases ranging from diabetes to
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neurodegenerative diseases such as Alzheimer’s disease
[13–18]. DNA methylation has been widely studied in
geroscience research as methylation at specific loci is
indicative of chronological age [19–22] and can potentially be an indicator of ‘biological’ aging [23, 24]. DNA
methylation primarily occurs in a CpG context; however,
non-CpG methylation is abundant in the central nervous
system (CNS) [1, 25] and has only been minimally examined with aging [26, 27]. With the growing understanding
that DNA methylation is dynamic, the role of alterations
in DNA methylation patterns in regulating gene expression changes during development, aging, and disease is of
particular interest.
DNA methylation changes with aging demonstrate
both tissue specificity and conservation across tissues
depending on the specific genomic location [28–30].
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Conserved changes with aging across tissues in the
form of epigenetic clocks have proved to be a powerful
tool for estimating chronological age and are predictive
of all-cause mortality [24, 31, 32]. Tissue-specific DNA
methylation changes with aging on the other hand may
underlie organ/cell-specific deficits. For example, in
the liver, gene body hypermethylation occurs primarily
in genes involved in lipid metabolism [33], while in the
brain age-related methylation changes occur in genes
involved in synaptic transmission and cellular integrity
[26]. It is important to note that changes in methylation
also occur in pathways implicated to be dysregulated
with aging systemically, such as the insulin-signaling
pathway and cellular senescence [34–37]. Recent studies
show that age-related DNA methylation changes in blood
[38, 39], kidney [40], liver [33, 37], and the hippocampus
[26], can be partially prevented by dietary, genetic, and
pharmacological pro-longevity interventions providing
further support for the association between DNA methylation and aging.
In the CNS, DNA methylation plays an important role
in cellular differentiation [41–43], synaptic formation and
function [44, 45], and in molecular mechanisms underlying learning and memory formation [46]. These processes
are known to be impaired with aging [47]; however,
whether age-related methylation differences contribute
to the decline of these processes is unknown. Global levels of DNA methylation have been proposed to decrease
with aging [48], but this has not been observed in brain
samples using modern sequencing techniques [49, 50].
Rather specific loci in the genome undergo hypermethylation and hypomethylation with aging [27]. In addition to
differences in methylation, with aging there is increased
variability in CpG methylation [51]. Similar findings are
observed in Alzheimer’s disease (AD) patients, specifically in genes directly linked to AD [17]. Thus, epigenetic
mechanisms may contribute to age-related impairments
and disease through altering gene expression, but little is known about the effects of age-related changes in
methylation on gene expression regulation in the brain.
Understanding the role age-related differential methylation plays in brain aging may allow for identification of
regulatory processes contributing to the development of
neuropathologies.
In previous studies we have characterized changes
in methylation and transcription with aging in the hippocampus of male and female mice, finding a core of
sex common changes with the majority of age-related
changes being sexually divergent [27, 52]. Here we sought
to understand the effect of age-related differential methylation on gene expression using paired DNA methylation, by whole-genome bisulfite sequencing (WGBS), and
transcriptome, by RNA-sequencing, data from the same
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samples. We find that differential methylation in gene
body and enhancer elements inversely correlates with
aging gene expression. This relationship is generally weak
and accounts for a small fraction of the differentially
expressed genes with aging. A stronger correlation was
observed between age-related differential gene expression and early-life promoter and gene body methylation patterns, an association that was independent of
age-related differential methylation. Furthermore, DNA
methylation levels were able to predict whether transcriptional changes with age will undergo up- or downregulation with aging. The predictive ability increased
when combined with other epigenetic marks. The broad
implication of our findings is that early programming of
the epigenome during development and/or early adulthood may impact transcriptional trajectories late in life.
Understanding epigenetic differences that occur during development may help explain late-life molecular
responses in the CNS and possibly differences in susceptibility to adverse conditions between individuals.

Results
Characterization of differential methylation
in the hippocampus using whole‑genome bisulfite
sequencing

To assess the relationship between hippocampal agerelated differential methylation and age-related transcriptional changes we first analyzed differential methylation
with aging using WGBS in both male and female mice.
Previous studies characterizing differential methylation
in the hippocampus with aging focused on just global
levels of methylation or used approaches that allowed
for high-resolution analysis of portions (~ 10%) of the
genome [27, 49]. Whole-genome bisulfite sequencing
provides the most comprehensive analysis of gene methylation by covering the majority of CpG sites across the
genome. Sequencing methods that examine smaller portions of the genomic CpG sites provide a limited and
incomplete view of genic methylation (Additional file 1:
Figure S1).
The average methylation level across all CpGs in young
(3 months) and old (24 months) animals demonstrate
no differences with aging (FY 74% ± 0.2, FO 73.5% ± 0.4,
MY 74.1% ± 0.5, MO 72.5% ± 1.4, Additional file 2: Figure
S2). Similarly, no difference in transposable element CpG
methylation with age was evident. No differences in average methylation levels between males and females were
observed. These agree with previous findings that there is
no hypomethylation with aging in the murine hippocampus [49, 50].
To determine regions of differential methylation, the
genome was binned to 500 bp non-overlapping windows. Windows with ≥ 10 CpGs and at least 3× coverage
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per CpG were retained yielding 979,603 regions analyzed for differential methylation with aging. Both
males and females had roughly similar numbers of agerelated differentially methylated regions (age-DMRs:
7702 in females vs 7029 in males) and showed a slight
bias towards hypomethylation (Fig. 1a–d). Only 2% of
all age-DMRs were common to both males and females
(Fig. 1b). Of these sex-common changes, 68% were commonly regulated, e.g., hypermethylated in both males and
females (χ2 test of independence p value = 1.3 × 10−6).
These results demonstrate that genome-wide, age-related
changes in DNA methylation are predominately sex-specific, in agreement with prior findings [27].
Functional enrichment of genes containing age-DMRs
revealed that although age-DMRs in males and females
occurred in different genomic locations, genes containing age-related differential methylation are enriched in
pathways with functional similarities, for example, genes
containing age-DMRs in females are enriched in inositol phosphate metabolism, while genes containing ageDMRs in males are enriched in phospholipid metabolism
and phosphoinositol metabolism (Fig. 1e, f, Additional
file 3: Table S1, Additional file 4: Table S2). Generally, pathways common to both males and females are
involved in glucose and lipid metabolism, neuronal interactions, and cellular integrity. These results suggest that
while sex-divergence occurs at the level of the genome,
the pathways affected by aging may still be functionally
similar.
Age-DMRs were assessed for their enrichment across
genomic features and gene regulatory elements. Overrepresentation of age-DMRs was observed in CpG islands
and shelves, and within gene bodies (Fig. 1g, h). Generally, DMRs were not enriched in promoter regions, but
when separated according whether the promoter contained a CpG island, significant enrichment of age-DMRs
is observed in promoters without a CpG island. This is
consistent with previous studies indicating that methylation of promoter CpG islands generally does not change
with aging [53, 54]. Age-DMRs were over-represented in
active and poised distal gene regulatory regions, namely
active enhancers and promoter flanks. This was also
evident by enrichment of age-DMRs in hippocampal
H3K27ac and H3K4me1 peaks, both indicators of active
and poised enhancers [55, 56] (Fig. 1e). Hypomethylated
age-DMRs were also over-represented in H3K36me3, a
marker of exons and transcriptional elongation [57, 58]
shown to be altered with aging and associated with longevity [59, 60], and in H3K27me3, a marker associated
with gene repression (Fig. 1g, h). Overall, enrichment of
age-DMRs in genomic regions suggest that methylation
of certain genomic regions is more susceptible to change
with age as compared with others.
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Association between differential gene expression
and differential methylation with aging

DNA methylation functions to modulate genomic architecture and regulate gene expression. However, the relationship of differential methylation to altered steady state
gene expression with aging has not been comprehensively addressed. We used RNA-sequencing to analyze
transcriptional differences with aging in the same samples used for methylation analysis and correlated ageDMRs with age-related differentially expressed genes
(age-DEGs) in the hippocampus. With aging 781 genes
were differentially expressed with aging in males and
433 in females (multiple linear regressions, fdr < 0.05 and
|FC| > 1.25) (Fig. 2a, b). Approximately 1/3 of the genes
upregulated with aging were common between males
and females (Fig. 2b), and only 22 downregulated genes
were common between the sexes (χ2 test of independence
p value < 2.2 × 10−16). This is consistent with previous
findings reporting sexual divergence in transcriptional
profiles in addition to a common core set of genes with
aging [52].
In both males and females, only a small number
of age-DEGs contained an age-DMR in their promoter region (± 1 kb of the TSS). The association
between age-DMRs and differentially expressed genes
with aging in promoters was not significant in both
males and females (Fig. 2c, f ). When assessing all ageDMRs independent of their location in the gene body
(TSS to TES), a weak negative correlation is observed
in both males (r = − 0.13, p = 0.039) and females
(r = − 0.25, p = 0.01) (Fig. 2d, g). On average, differentially expressed genes and those not changing in
expression with aging had similar methylation values
across their gene bodies (Additional file 5: Figure S3).
Given that DNA methylation can regulate gene transcription through changes in enhancer regions we
examined the correlation between age-DMRs mapped
to enhancer regions (determined by H3K27ac ChIP
data from cortex) and transcriptional changes of their
nearby genes. A significant negative correlation was
observed between age-DMRs in enhancer regions and
age-DEGs in both males (r = − 0.21, p = 0.018) and
females (r = − 0.25, p = 0.04) (Fig. 2e, h). Age-DMRs
mapped to gene bodies or enhancers associated with
genes that were not differentially expressed with aging
resulted in significant, but very weak negative correlation (r < 0.1) in both males and females (Fig. 2d, e, g, h).
Taken together, age-DMRs may explain a small portion
of the transcriptional changes that occur with age, and
generally this effect is observed in enhancers and gene
bodies, but not promoters. These findings are in agreement with recent studies in the liver showing a limited
inverse association between gene body methylation
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baseline methylation in young animals in males (b) and females (c). d Overlap between age-DMRs in males and in females and the directionality of
methylation changes of common age-DMRs. Pathway enrichment of genes containing age-DMR within their gene body in females (e) and in males
(f). Significant enrichment was determined by hypergeometric test (p < 0.05). g, h Over- and under-representation of age-DMRs in genic regions,
CpG islands, and regulatory elements in the brain divided by their activation state, and regulatory elements annotated by specific histone marks in
males and females. Over- and under-representation were determined using hypergeometric test (p < 0.05)
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with aging and gene repression of genes involved in
lipid metabolism and growth hormone signaling [33].
Additionally, DNA methylation changes poorly correspond with transcriptional changes in the CNS during neuronal maturation [41] or following induction of

methylation in culture [61]. Therefore, while the canonical regulation of gene transcription by DNA methylation is likely to explain a portion of the age-associated
differential gene expression, age-related differential
methylation may potentially serve a more complex role
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in transcriptional regulation than simply induction and
suppression of steady-state gene expression.
Age‑related gene expression changes are associated
with methylation profiles in early life

DNA methylation can play multiple roles in regulating gene transcription by altering protein binding occupancy [62], regulation of alternative splicing [63–67],
and through interactions with histone marks [11, 68].
To examine relationships between DNA methylation
patterns and gene expression with aging and gene body
methylation levels (mean methylation from TSS to TES)
(Fig. 3a, b) in early and late life were examined. Intriguingly, genes differentially expressed with aging show a
moderate positive association between age-related differential mRNA expression and gene body methylation
levels at both young and old age (Fig. 3a, b). Genes whose
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Fig. 3 Age-related differentially expressed genes are positively associated with gene body methylation. Genes downregulated with aging have
lower gene body methylation at young age (Y, blue regression line) in both males (a) and females (b) compared to genes upregulated with aging.
This relationship is maintained in old age (O, red regression line). Curve corresponds to polynomial regression curve across significant (red and
blue) and non-significant (N.S., black) differentially expressed genes, 95% confidence intervals are shaded by the grey area. Gene body methylation
was calculated as methylation of all cytosines between the transcription start site and transcription end site of a given gene. Box plot of whole
gene methylation grouped by genes upregulated, non-differentially expressed, and downregulated genes in males (c) and females (d) *p < 0.001
(Kruskal–Wallis Test). Heatmaps illustrating the per-gene gene body methylation patterns of genes upregulated and downregulated with aging in
young and old, male (e) and female (f) animals
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(Fig. 4a, b), and was comparable in both sexes (Fig. 4c–
f, Additional file 6: Figure S4C, D). Genes that do not
change in expression with aging showed a weaker association that was not consistent between males and females
(Fig. 4a, b). The correlation between promoter methylation levels and gene expression changes was greater compared to observed with gene body methylation and was
independent of apparent age changes in methylation. Our
observation reveals a relationship between age-related
gene expression changes and DNA methylation that
depends on the methylation patterns established early
in life rather than differential methylation with aging.
To determine whether the positive association between
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regulation. Although transcriptional changes with aging
are predominately sex-specific, this association was evident in both males and females (Fig. 3), with males showing a stronger association as compared to females.
Qualitative assessment of the DNA methylation
landscape of up- and downregulated genes with aging
revealed that the main difference between up- and downregulated genes occurs primarily around the transcription
start site (Fig. 3e, f ). Therefore, we repeated the analysis
focusing on promoter methylation defined as ± 1 kb of
the TSS. The positive association between differentially
expressed genes and baseline DNA methylation was
recapitulated when examining only the promoter region
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Fig. 4 Age-related differentially expressed genes are positively associated with promoter methylation. Genes downregulated with aging have
lower promoter methylation at young age (Y, blue) in both males (a) and females (b) compared to genes upregulated with aging. This relationship
is maintained with aging (O, red). Curve corresponds to polynomial regression curve across significant (red and blue) and non-significant (N.S.,
black) differentially expressed genes, 95% confidence intervals are shaded by the grey area. Promoter is defined as ± 1 kb from transcription start
site. Box plots of promoter methylation grouped by genes upregulated, non-differentially expressed, and downregulated genes in males (c) and
females (d) *p < 0.001 (Kruskal–Wallis Test). Heatmaps illustrating promoter methylation patterns of genes upregulated and downregulated with
aging in young and old in male (e) and female (f) animals
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DNA methylation patterns and transcriptional changes
with aging is observed in other tissues, we performed
our analysis using paired WGBS and RNA-sequencing
in the liver [33] (data obtained from GEO:GSE92486). A
positive relationship between fold change and gene body
methylation was observed with the liver data similar to
that observed in the hippocampus (Additional file 7: Figure S5). The lack of whole-genome bisulfite sequencing
data with aging in other tissues prevents further extension and validation of relationship at this time.
Association of methylation patterns with transcriptional
changes with aging is not random

Differentially expressed genes with aging appear to have
a different DNA methylation profile compared to genes
that are stably expressed across the lifespan (Figs. 3, 4).
To determine whether this observation is unique to genes
that are differentially regulated with aging, we used a
random sampling approach to correlate gene body DNA
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methylation values with their corresponding mRNA fold
change with aging. Randomly sampled sets of 500 genes
(n = 10,000) showed weak correlation (r < 0.1) similar to
that of genes not differentially expressed with aging and
much less compared to that observed for genes differentially expressed with aging (r > 0.4) (Fig. 5a).
Next we asked whether genes sets that belong to
the same pathway present a similar positive association. Pathways were extracted from the Reactome pathway database [69], and used as gene sets for correlation
between methylation levels at young age and mRNA
fold change with aging. After filtering pathways containing < 50 genes, 368 pathways remained for the analysis
(Fig. 5b). Out of all the pathways analyzed, 35 pathways
showed a correlation coefficient that met or exceeded
the correlation coefficient of r > 0.4 (Fig. 5c) observed
between promoter methylation and genes differentially
expressed with aging. For gene body methylation 32
pathways met or exceeded the correlation coefficient
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Fig. 5 The association between differential expression and DNA methylation patterns in young animals is not random. a Distribution of the
correlation coefficients generated by correlating log2 fold mRNA change with gene body methylation of 500 randomly sampled genes (N = 10,000).
Arrow indicates the location of the correlation coefficient of gene body methylation and differentially expressed genes in males. Snippet showing
the polynomial regression curves of randomly selected gene sets compared to that observed in males (black regression line). b Correlation
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each Reactome pathway gene set
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methylation profiles would be observed. To identify genes
altered following neurodegeneration in the hippocampus,
we used published RNA-sequencing data from two models of AD (APP and Ck-p25) and examined whether gene
body and promoter DNA methylation levels in young and
old animals are associated with differential gene expression observed in a neurodegenerative disease model.
A significant number of genes were unique to each of
the models; however, significant overlap was observed
between both AD models and with genes altered with
aging (APP:Aging χ2 p < 2.2 × 10−16; CK-p25:Aging χ2
p < 2.0 × 10−14; APP:CK-p25 χ2 p < 2.2 × 10−16) (Fig. 6a).
As observed with genes differentially regulated with
aging, upregulated genes with both APP and CK-p25
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cutoff (Fig. 5d) and were observed only in males. Pathways that showed the highest correlation between DNA
methylation patterns and transcriptional change with
age were pathways previously shown to be involved with
aging included inflammatory pathways (transcriptional
regulation by RUNX1, MHC II signaling, interferon signaling), oxidative stress, proteolysis, cell senescence, epigenetic regulation, and estrogen signaling (Additional
file 8: Table S3, Additional file 9: Table S4).
A central geroscience concept is that age-related
changes intersect with those involved with disease pathogenesis, including Alzheimer’s disease [18, 70]. Therefore,
we hypothesized that a positive correlation between transcriptional changes with neurodegeneration and DNA
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FO

Fig. 6 DNA methylation patterns in hippocampus of young and old animals are associated with genes differentially regulated in models of
neurodegeneration. a Venn-diagram representing the overlap between genes differentially expressed in two models of neurodegeneration
(APP and CK-p25) and genes differentially regulated with aging (males and females combined). Heatmaps illustrating the per-gene gene body
methylation patterns of young and old animals (females only) in genes upregulated and downregulated in two models of neurodegeneration (b
APP, c CK-p25). Box plots of gene body (d, f) and promoter (e, g) methylation grouped by genes upregulated, unchanged or downregulated in APP
(d, e) and CK-p25 (f, g)
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had significantly higher mean methylation in early life
compared to downregulated genes (Fig. 6b, c). This was
observed for gene body (Fig. 6d, f ) and promoter methylation (Fig. 6e, g) as well. Differences in methylation in
these models were not examined, therefore a potential
difference in methylation due to AD pathology as a driving mechanism of differential gene regulation cannot be
excluded; however, our findings suggest that genes differentially regulated with neurodegeneration may be more
susceptible to change due to their methylation profile in
a manner similar to that observed for genes differentially
expressed with aging.
DNA methylation‑based prediction of differential
expression with aging

Given the distinction in early-life methylation patterns
among age-related differentially expressed genes, we
investigated the early-life patterns of other epigenetic
marks known to interact with DNA methylation in
genes that are up and downregulated with aging. Using
publicly available data sets of histone marks maps generated from the young mouse hippocampus and cortex
(H2Bac, H3K27ac, H3K27me3, H3K36me3, H3K4me3,
H3K9me3, and H2A.Z), we profiled each age-related differentially expressed gene’s epigenetic landscape using
DNA methylation data and the gene’s calculated histone breadth of coverage. A principal component analysis (PCA) based on genes’ epigenetic profiles revealed a
separation between upregulated genes and downregulated genes. Combined PC1 and PC2 explained 90% of
the variance between upregulated and downregulated
genes (Fig. 7a). Correlation of the first component eigenvectors with the original epigenetic variables showed
strong positive correlation with DNA methylation and
negative correlation with active transcription marks such
as H3K27ac, an active enhancer mark and H3K4me3,
an active promoter mark (Fig. 7b). This suggests that
at baseline (young age), genes that undergo expression
changes with aging are under different epigenetic regulation during earlier time-points. Interestingly, the second principle component (variance explained 28.7%)
shown the opposite correlation as the first components
and was negatively correlated with gene body methylation and active transcription marks (Fig. 7b). Together
this shows that genes differentially expressed with aging
have different epigenetic patterns, starting in early life.
This early-life epigenetic landscape may alter these genes’
responsivity to aging. As expected, not all genes differed
according to their epigenetic profile. A subset of genes
showed a similar epigenetic profile regardless of their
expression trajectory.
Next, we set to investigate the associations between
different epigenetic marks in age-related differentially
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expressed genes. Genes were separated by up and downregulation with aging and the interactions between the
different epigenetic marks were investigated. While
the baseline epigenetic profile of genes appear to differ
between up and downregulated genes (Figs. 3, 4, 7a, b),
the interactions between these epigenetic marks remain
consistent between up and downregulated genes. Promoter and gene body methylation were positively correlated with one another in both gene groups, and as
expected were negatively correlated with active enhancer
and promoter marks, H3K27ac and H3K4me3 (Additional file 10: Figure S6A, B). While the interactions
between epigenetic marks did not change between differentially expressed genes with aging, similar to DNA
methylation levels, the baseline levels of different histone marks were different between up and downregulated genes. Genes that were downregulated with aging
show higher breadth of coverage of active transcription
marks compared to upregulated genes (Fig. 7c). This is
consistent with the lower promoter methylation levels
observed in these genes. Interestingly, the gene size of
up and downregulated genes was also different between
up- and down-age-related differentially expressed genes
with upregulated genes significantly longer than downregulated genes (Fig. 7c). Together, these findings further
demonstrate that altered epigenetic patterns may contribute to the trajectory of change of genes changing with
aging.
To strengthen the potential link between differences
in epigenetic landscape in young age and differential
expression observed late in life we used random forest
(RF) modeling to find whether early-life epigenetic patterns can predict gene expression changes with aging.
The RF models were trained to predict the direction of
transcriptional change with age (upregulated or downregulated) based on methylation data, gene size, relative
expression in young age expressed by RPKM, and the epigenetic marks annotated in the hippocampus and cortex
obtained from publicly available data sets (see methods).
The trained RF model was able to correctly classify
transcriptional changes with high accuracy in both males
(87%) and females (78%) (Fig. 7d, e). RF performance
decreased slightly when trained based on DNA methylation means and RPKM alone, but still performed significantly better than random in both males (78%) and
females (71%) (Additional file 10: Figure S6C, D). Evaluation of feature importance to each of the RF models
revealed that DNA methylation and gene size are highly
important for predicting gene expression in both sexes.
In males, gene size, H2A.Z marks, H3K4me3, H3K27ac,
and DNA methylation averages of both whole gene and
promoters (Fig. 7f ) contributed the most to predictive
accuracy. In females, high importance features for model
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Fig. 7 Direction of change of age-related differentially expressed genes can be predicated based on epigenetic marks in young age. Principle
component analysis of epigenetic profiles of upregulated and downregulated genes with aging in the hippocampus (a). Correlation matrix
representing the correlations between each principle component with epigenetic marks (b). Box plots comparing highly correlated epigenetic
marks with the first principle component in upregulated and downregulated genes with aging (c). Area under the curve of the receive operating
characteristic (ROC) curve showing the classification accuracy of differentially expressed to upregulated and downregulated genes for Random
Forest model in males (d) and females (e). Feature importance of epigenetic marks for classification accuracy (mean decrease accuracy and mean
decrease gini) in males (f) and females (g)

prediction included mean expression, DNA methylation
levels and gene size (Fig. 7g). Feature importance measures of histone breadth of coverage were much lower in
females compared to males. This is likely due to well-documented sex-differences in histone landscape observed
in both mice and humans [71], which were not accounted
for in the current analysis as most histone data available

for hippocampus obtained for the analysis were collected
from male animals.
It should be noted that these different epigenetic
marks are not independent of each other as DNA methylation is closely associated with both H3K4me3, an
active promoter mark [72], and H3K27ac, an enhancer
mark [73]. Regions of H3K4me3 and H3K27ac often

Hadad et al. Epigenetics & Chromatin

(2019) 12:58

act coordinately with DNA methylation during gene
transcription regulation [74]. Local depletion of DNA
methylation is a hallmark of H3K4me3 and H3K27ac
[56], and thus these marks are considered to be regulated by DNA methylation. Gene size was a significant
contributor to the accuracy of the models (Fig. 7c, d),
the relationship between gene length and DNA methylation is still not completely understood; however, transcription of long genes may be partially regulated by
DNA methylation. For example, in the CNS transcriptional regulation of long genes is mediated through the
DNA methylation binding protein MeCP2 [75]. The
results presented here are in agreement with those of
Benayoun et al. [76] which examined some of these
marks but not DNA methylation in the cerebellum and
olfactory bulb. Taken together, these results put forward the concept that epigenetic regulation at a young
age may direct transcriptional change with aging.

Discussion
These studies reveal, by analyzing the methylation and
transcriptional profiles in the hippocampus of young
and old animals, evidence for a potentially novel role for
DNA methylation in regulating transcriptional changes
with age that is independent of age-related changes
to the methylome. These data demonstrate a propensity for genes to be upregulated or downregulated in
expression with aging based on their methylation profiles established early in life. Additionally, differences
in methylation with age are enriched in exonic and
intronic regions, and showed a weak inverse correlation
with differences in gene expression. The functional role
of gene body methylation is not yet well defined but is
associated with transcriptional elongation [77], splicing [64, 65, 67, 78], regulation of alternative promoters
[79], and modulation of expression levels through interaction with methyl-binding proteins such as MeCP2
[80, 81]. In the CNS, in contrast to other tissues, gene
body methylation is inversely correlated with expression levels [1, 82], a relationship observed here. The
diverse functional roles of gene body methylation create a challenge in interpreting the association between
gene body age-DMRs and the altered transcriptional
profile with aging. Nevertheless, age-related differential methylation within genes is common to various tissues; therefore, improved knowledge on how gene body
methylation regulates expression is required to understand the potential functions age-DMRs play in regulation of the aging transcriptome. Together these findings
emphasize the importance of gene body methylation,
in addition to promoter regions, as a gene expression
regulatory mechanism.
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Association of promoter age‑DMRs with age‑DEGs
is limited

The association between DNA methylation and gene
expression is often derived from the inverse correlation
between mRNA expression and DNA methylation in
promoters under normal conditions [8]. While differences in promoter methylation in the hippocampus occur
with aging, the genes associated with these promoters are
generally not differentially expressed with age (Fig. 2).
A potential explanation is that observed changes to the
methylome with age are subtle and therefore insufficient
to induce transcriptional differences, however, a weak
correlation between gene expression changes and differential promoter methylation is also observed in studies of
cancer and cellular differentiation [83, 84], which include
disruption to- (cancer) or reprogramming of- (differentiation) the methylome. The limited correlation between
age-related differential promoter methylation and gene
expression changes does not preclude differential promoter methylation from altering expression of specific
genes, but is insufficient to explain the majority of transcriptional changes observed with age in the hippocampus. It should also be noted that gene expression changes
rapidly with stimuli and the expression levels here were
collected to represent steady-state expression levels. As
well, examination of specific call types or even single cells
is needed as these data represent a mix of cell types present in the hippocampus.
Enhancer age‑DMRs are related to age‑DEGs

Recent studies identified that altered DNA methylation patterns play a greater role in explaining transcriptional changes when they occur in distal regulatory
regions, namely enhancers, compared to gene promoters
[84]. Age-related differential methylation is enriched in
enhancer marks in various tissues [37, 85–87], including
in the hippocampus [26]. With aging, altered methylation
in differentiating cells, specifically hypomethylation, was
shown to be enriched in regions marked by H3K4me1
[88], a marker of active and poised enhancers [89], and
is thought to activate gene expression. Consistent with
these findings, we found enrichment of both hyper- and
hypo-methylated age-DMRs in regions distal to gene
promoters, specifically in annotated active and poised
enhancers. These age-DMRs were inversely correlated
with transcriptional differences with aging in both males
and females.
Recent findings shed light on the interaction between
the enhancer marks H3K27ac and H3K4me1 and DNA
methylation and the functional role of this interaction on
gene transcription regulation [90]. Enhancer activation
can be both positively or negatively associated with DNA
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methylation depending on the regulatory nature of the
enhancer and the developmental stage of the organism
[55, 56, 91]. Enhancers containing transcription factor
binding motifs tend to be inversely correlated with DNA
methylation late in life, but not during cellular differentiation where DNA methylation increases in enhancers
proximal to genes that involve cellular specification [74].
Methylation of super-enhancers is thought to contribute
to the structural integrity of the genome at these regions
[91, 92]. Although alterations in chromatin landscape
with aging have been reported, few studies have mapped
altered histone marks with age. H2A.Z, a histone variant
needed for the acetylation of histone 3 lysine 27 [93], does
change with aging in the hippocampus [94], and may be a
contributing mechanism to enhancer mark changes with
aging. Given these results we hypothesize that changes in
methylation can potentially alter transcription through
attenuation of enhancer strength rather than facilitating deposition of H3K27ac. Future studies will need to
address this hypothesis by mapping the differences in
enhancer landscape with age in both male and female
and in different cell/tissue types.
A unique feature of genes that were differentially
expressed with age was their association with DNA methylation patterns established in early life (i.e., methylation
levels in young animals). Methylation levels of upregulated genes were higher than levels of downregulated
genes in young animals, this difference persists in old
animals and therefore was generally independent of agerelated differential methylation. The association between
methylation levels and expression was not observed
for genes that were not altered with aging or randomly
selected genes. Furthermore, gene expression changes
with aging were generally different between males and
females, yet a similar association was observed in both
sexes. This finding supports the concept that, based on
their epigenetic patterns established early in life, specific
genes have a higher propensity to change with age than
others and that their induction/reduction is dependent
on the methylation status of the gene. Therefore, suppression or induction of genes with aging is likely to occur
downstream of methylation by factors that interact with
the methylome such as histone modifications or methylbinding protein dynamics. An additional finding was that
genes that changed with age and correlated with early-life
methylation occur in specific gene sets that function in
similar pathways. This is consistent with the notion that
genes with similar functions are regulated in similar ways
[95, 96].
Using the predictive capabilities of machine learning we were able to show that baseline gene expression
and DNA methylation levels alone can classify whether
differentially expressed genes will be downregulated or
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upregulated. When other epigenetic marks from the
young/adult brain are added to the model, the classification accuracy of the model improves. This provides further support to the idea of early epigenetic programming
as a determining factor of expression changes with age.
A recent study [76] showed similar results by predicting age-related expression changes based on chromatin
marks. The authors found that changes in the enhancer
mark H3K27ac with age were among the highly important features for accurate classification. This indicates
that age-related alterations to the epigenome contribute
to transcriptional changes with age. Although changes
in chromatin predict gene expression changes well, we
were able to achieve similar predictive capabilities based
on early-life DNA methylation alone, and in both males
and females. Future studies combining both baseline epigenetic profiles and age-related alteration to histones are
needed to improve the classification accuracy of these
models, and perhaps help identify the interplay between
mechanisms that underlie epigenetic regulation of transcriptional changes with aging.
Aging processes are thought to promote the development of age-related neurodegenerations like AD and PD
[47]. In our study we find that the association between
early-life methylation patterns and differential gene
expression is also observed in genes that are dysregulated
in mouse-models of AD. That is, genes that were upregulated in a model of neurodegenerative disease had higher
gene body methylation at young age compared to those
that were downregulated. Thus, it is plausible that DNA
methylation patterns established at young age may facilitate transcriptional changes and more severe conditions
in late life as well. Given that genetic differences are associated with age-related transcriptional differences [97],
and increased longevity in supercentenarians [98, 99] it is
entirely plausible that early-life epigenetic patterns could
have similar impacts. This raises the question of what
may cause epigenetic differences in early life that have
late-life outcomes.
Early-life events such as differences in maternal care,
nutrition, or adverse events can cause long-lasting alterations to the neuroepigenome [100–102]. Therefore, epigenomic programming during developmental stages and
early adulthood may serve as a potential mechanism for
altered late-life outcomes, including aging and susceptibility to disease. In addition, DNA methylation patterns
are also altered with anti-aging therapies that have a beneficial effect on molecular and cellular aging hallmarks
[26, 37]. These therapies, for example calorie restriction,
have been shown to be potent in a short window early in
life and following life-long treatment [103, 104]. A point
for further investigation is how these anti-aging therapies
can alter methylation patterns both early and late in life
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to prevent age-related transcriptional changes and promote a pro-longevity phenotype.

Conclusions
Age-related differences in epigenetic marks are likely to
contribute to transcriptional alterations, however, these
epigenetic differences account for a small subset of the
gene expression changes with aging and are dependent
on the genomic location, e.g., promoter vs. regulatory
region. It is noteworthy that our current knowledge of
the exact location of regulatory marks is far from complete and is likely to vary between cell types, tissues, and
sexes. It would be important to test predictive validity with improved and more complete data sets as well
as refined locations of TSSs, alternative splice sites, and
gene regulatory marks. Our current findings identify a
potential new way in which DNA methylation can influence age-related transcriptional change. The early establishment of DNA methylation patterns of a gene appears
to partially determine whether the gene will change with
age and the directionality of the change. Interestingly, a
recent manuscript identified a similar finding examining histone modifications in the cerebellum and olfactory
bulb [76]. We also observed this association with aging
in the liver and in Alzheimer’s disease models. Together,
these findings indicate that the early-life epigenetic landscape of a gene may direct its gene expression trajectory
with aging and age-related disease. These findings provide a potential mechanism for the developmental origins of disease concept [105].
Materials and methods
Animals and nucleic acid extraction

Male and female C57BL/6 mice were obtained from the
NIA aging colony at 2 and 21 months of age. Mice were
housed at the University of Oklahoma Health Sciences
Center barrier animal facility and maintained under SPF
conditions until 3 and 24 months of age. All experimental procedures were performed according to protocols
approved by the OUHSC Institutional Animal Care and
Use Committee. Mice were euthanized by decapitation
and hippocampal tissue was dissected and snap-frozen
until used for DNA and RNA extraction. DNA and RNA
from young and old animals (n = 6/group) were isolated
from hippocampal tissue using Zymo Duet DNA/RNA
(Zymo research).
Whole‑genome bisulfite sequencing and DMR calling

Isolated genomic DNA from young and old animals
(n = 3/group) was used for Whole-Genome Bisulfite
Sequencing (WGBS). Bisulfite conversion was carried out using EZ DNA methylation Lighting (Zymo
Research, Irvine, CA) and library construction used Swift
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Accel-NGS methyl-seq kit reagents (Swift Bioscience,
Ann Arbor, MI) following manufacturer’s instructions.
Library size was assessed by Tapestation (Agilent Technologies, Santa Clara, CA) and quantified by quantitative PCR (Kappa Biosystems, Wilmington, MA) prior to
sequencing. BS-seq libraries were sequenced by 100 bp
paired-end reads on the Illumina HiSeq-2500 (Illumina,
San Diego, California, USA). Sequencing data will be
made available upon manuscript submission.
Paired-end reads were trimmed using trimmomatic
version 0.35 [106]. Reads were adapter-trimmed and filtered based on quality. Bases with a Q-score < 30 were
removed from the 5′ and 3′ ends. Reads were quality-filtered using a sliding window approach (parameters were
set to 5:30). Additionally, reads shorter < 25 bp post-trimming were removed. Trimmed PE reads were aligned to
the mouse reference genome (GRCm38/mm10) with Bismark Bisulfite Mapper version 0.14.4 [107] using default
settings. Methylation % and coverage of each CpG site
were extracted with bismark methylation extractor. Mean
coverage per sample was 5× (± 0.4 SD). For differentially
methylated regions calling, sites with < 5× mean coverage per group were removed resulting based previous
sequencing recommendations [108] in > 20 million CG
sites analyzed (Additional file 11: Figure S7).
To determine differentially methylated regions (ageDMRs), the genome was binned into consecutive, nonoverlapping 500 bp windows. Samples within each group
were combined to achieve higher coverage per site, and
windows with < 10 CpG sites were omitted from the analysis (Additional file 11: Figure S7). The number of CpGs
per widow was determined based on approximation of
CpG density, Statistical significance of differential methylation was determined using Fisher’s exact test followed
by false-discovery multiple testing correction. Differentially methylated regions were considered statistically different if FDR-adjusted p value < 0.05.
RNA sequencing and differential gene expression analysis

RNA integrity was quantified by TapeStation (Agilent
Technologies, Frankfurt, Germany) and samples had
RNA integrity numbers > 8. RNA-sequencing libraries
were prepared using Illumina’s TruSeq RNA-seq library
prep with a rRNA depletion step according to manufacturer’s instructions. Libraries were sequenced with
150 bp paired-end (PE) reads on the Illumina HiSeq 4000
platform (Illumina, San Diego, California, USA) (n = 6/
group). Sequence quality control was performed with
fastQC. Following QC step PE reads were trimmed similarly to the WGBS sequences using trimmomatic.
Following QC and trimming, reads were aligned to
the mouse (mm10) reference genome using STAR [109].
For alignment, the genome was prepared based on
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GENCODE M15 release. STAR Alignment parameters
were set to: outFilterScoreMin 2, outFilterMultimapNmax 5, outFilterMismatchNmax 10, outFilterMatchNmin
20, outSJfilterReads Unique, outSJfilterOverhangMin 25
10 10 10, alignSJoverhangMin 2, alignSJDBoverhangMin
2, chimSegmentMin 25. Reads per gene were counted in
R using the ‘summarizeOverlap’ function in the GenomicAlignments package. Raw reads were normalized using
DESeq 2 R package [110] and transformed using variance stabilized transformation. Differential expression
between all groups was assessed using multiple linear
regression (R package ‘glm’) using read counts as the
dependent variable and age (young and old) and sex
(male and female) as the independent variables. Genes
with significant age main effect (p < 0.05) were then carried on for pair-wise comparisons using Conover posthoc test followed by false discovery rate adjustment using
‘fdr’ as implemented in the R package ‘lsmeans’.
Enrichment analysis

For pathway enrichment age-DMRs were annotated
using ChIPseeker [111], and enrichment analysis was
performed using the R package ‘ReactomePA’ [112]. To
determine over- and under-representation of DMRs in
genomic features, annotated introns, exons, and CpG
islands were obtained from UCSC Genome Browser.
Promoters were defined as ± 1 kb from the transcription
start site. CpG shores were defined as 2 kb upstream
and downstream of the annotated CpG island boarders and CpG shelves were defined as 2 kb upstream and
downstream from shores. Of the 18,000 genes identified
to be expressed in our set, > 94% had a DMR mapped to
their gene body, and > 85% had a DMR mapped to their
promoter (Additional file 11: Figure S7). Gene-regulatory regions in the mouse brain were extracted from
Ensemble open database [113]. DMRs were mapped to
genomic features using ‘bedtools’ [114]. Statistical significance of over- or under-representation of DMRs in
genomic features was determined using hypergeometric
test in R.
Differential expression prediction

Differentially expressed mRNAs with aging were classified based on the directionality of change (upregulated
or downregulated) and divided into a training set and a
validation set by randomly subsetting 70% of the genes
to the training set, the remaining genes were used for
model validation. Prediction of gene change directionality with aging was performed separately for male and
females. Random forest (RF) was used for prediction,
and all analysis and cross-validation was performed in
R using the ‘randomforest’ package. The RF model was
trained based on selected epigenetic features including
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mean gene DNA methylation in young and old, mean
promoter (± 1 kb of TSS) methylation in young and old,
gene size, base expression at 3 months, and breadth of
coverage of the following histone marks: H2A.Z from
young and old animals, H3K27ac, H3K36me3, H3K4me3,
H3K27me3, H2Bac, and H3K9me3. Breadth of coverage
was calculated by the breadth sum of all peaks in a gene/
gene length.
Public data acquisition

Paired methylation and differential expression data for
liver were obtained from GEO:GSE92486 [33]. Differential genes expression for age-related neurodegenerative
disease APPswe/PS1ΔE9 (APP) and Ck-P25 models were
obtained from GEO:GSE93678 [115] and GEO:GSE65159
[116]. Only WT control and experimental groups were
used. ChIP-sequencing data of hippocampal histone
marks were obtained from GEO:GSE85873 (H3K4me3
and H3K27me3) [117], GEO:GSE103358 (H2Bac), and
GEO:GSE100039 (H2A.Z) [94]. Cortex epigenetic marks
including H3K27ac, H3K36me3, and H3K9me3 were
obtained from GEO: GSE103214 [118]. Peak calling was
determined with MACS2 [119].
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Additional file 1: Figure S1. Distribution of gene body methylation
using RRBS and WGBS. A comparison of the distribution of gene body
methylation across all genes in the liver measured by reduced representa‑
tion bisulfite sequencing (RRBS) and whole-genome bisulfite sequencing
(WGBS) obtained from GEO:GSE92486. RRBS covers methylation over por‑
tions of 23,000 genes as compared to near complete coverage of 29,000
genes by WGBS. The gene body methylation profiles obtained by RRBS do
not represent the gene body methylation values observed by WGBS, likely
in part due to the preference of RRBS for regions of high CG density which
often have low levels of methylation (e.g., CpG Islands).
Additional file 2: Figure S2. Global DNA methylation levels measures
using WGBS. A) Box plots of whole-genome methylation in young and old
males and females. Box plots showing the methylation levels of cytosines
mapped to all transposable element regions (B) or to specific transposable
element families. Long interspersed nuclear repeats, LINEs (C), small inter‑
spersed nuclear repeats, SINEs (D), DNA transposons (E), and long terminal
repeats, LTRs (F), n = 3/group.
Additional file 3: Table S1. List of Reactome pathways enriched with
age-related DMRs.

Additional file 4: Table S2. List of Reactome pathways enriched with
age-related DMRs separated by hypermethylation and hypomethylation.
Additional file 5: Figure S3. Baseline gene body methylation is not
different in age-related differentially expressed genes from those who do
not change with age. A-F) line plots representing the average methyla‑
tion across all genes that were not significantly differentially expressed
with aging (A, D), downregulated with aging (B, E), and upregulated with
aging (C,F) in females (A-C) and males (D-F). Black line represents young
animals, red line represents old animals. Grey shading represents the 95%
confidence intervals.
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Additional file 6: Figure S4. Positive association between methylation
and gene expression is limited for CH methylation. Box plots of whole
gene (A, B) or promoter (C, D) CH methylation in females (A, C) and
males (B, D) grouped by genes that are upregulated, downregulated, or
unchanged with aging in the respective group.
Additional file 7: Figure S5. Age-related differentially expressed genes
are positively associated with gene body methylation in the Liver A) Genes
downregulated with aging have lower gene body methylation at young
age (blue regression line) compared to genes upregulated with aging in
the liver. This relationship is maintained with aging (red regression line).
Curve corresponds to the polynomial regression curve across significant
(red and blue) and non-significant (black) differentially expressed genes.
B) Box plot of whole gene methylation grouped by genes upregulated,
non-differentially expressed, and downregulated genes in the liver. *p <
0.001 (Kruskal–Wallis Test).
Additional file 8: Table S3. Reactome pathways presenting high correla‑
tion between age-related expression fold change and early life gene body
methylation patterns.
Additional file 9: Table S4. Reactome pathways presenting high cor‑
relation between age-related expression fold change and early life gene
promoter methylation patterns.
Additional file 10: Figure S6. Direction of change of age-related dif‑
ferentially expressed genes can be predicted based on DNA methylation
profiles. Correlation matrices of different epigenetic features in down‑
regulated genes with aging (A) and upregulated genes with aging (B).
Area under the curve of the receive operating characteristics (ROC) curve
showing the classification accuracy of age-related differentially expressed
genes to upregulated and downregulated genes for Random Forest
model in males (C) and females (D) trained based on baseline methylation
and promoter and gene body DNA methylation. TRatio—gene ratio; wg—
whole gene; tss—transcription start site; my—male young; mo—male
old.
Additional file 11: Figure S7. Sequencing alignment and differentially
methylated region calling summary statistics. A. Boxplots representing the
mapping efficiency per group. B. Overall genomic sequencing coverage.
C. Boxplots showing the number of CpGs covered. D. Boxplots represent‑
ing the average CpG coverage per group. E. Line plot of the number of
DMRs mapped to genes (black and red) and gene promoters (green and
blue) passed filtering from RNA-sequencing. F. Line plot showing the
number of CpG in regions passed filtering for differential methylation.
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